Production (Stage)
Autolus Therapeutics plc
AUTL
$1.54
$0.010.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -154.15% | 66.37% | -40.88% | -10.59% | 31.72% |
| Total Depreciation and Amortization | 9.63% | 7.17% | 2.27% | 4.93% | 1.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 206.36% | -765.65% | -90.04% | -41.09% | -9.87% |
| Change in Net Operating Assets | -492.73% | -249.23% | 122.44% | 35.16% | -157.79% |
| Cash from Operations | -99.20% | 50.57% | -50.23% | -26.09% | -63.15% |
| Capital Expenditure | 25.82% | -15.88% | -1,040.19% | -57.79% | 63.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 86.23% | -- | -- | -- | -- |
| Cash from Investing | 84.48% | -3,900.30% | -1,040.19% | -57.79% | 63.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -96.22% | 48.00% | -99.98% | 2,392,343.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -119.72% | -- |
| Cash from Financing | -- | 16,120.00% | 108.90% | -100.37% | 2,440,947.83% |
| Foreign Exchange rate Adjustments | 109.31% | -201.31% | 2,560.23% | 219.66% | -112.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.39% | -787.47% | 7.92% | -110.13% | 3,244.05% |